1. P708: CANADIAN AND RUSSIAN EXPERIENCES OF ASCIMINIB IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WHO FAILED MULTIPLE LINES OF TYROSINE KINASE INHIBITOR (TKI) THERAPY. (23rd June 2022) Authors: Khadadah, F.; Turkina, A. G.; Lomaia, E.; Morozova, E. V.; Shukhov, O. A.; Petrova, A.; Chitanava, T.; Vlasova, J. J.; Kuzmina, E.; Nemchenko, I.; Chelysheva, E. Y.; Bykova, A.; Gurianova, M.; Xenocostas, A.; Busque, L.; Jamani, K.; Cerquozzi, S.; Kuruvilla, P.; Kaedbey, R.; Leber, B. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗